Armata Pharmaceuticals, Inc. (ARMP)
↓ Download CSV| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income | -$36.63M | -$42.44M | -$40.89M | -$36.95M | -$23.82M | -$21.59M | -$19.75M | -$17.66M | -$16.16M | -$23.38M |
| Net Income | -$173.80M | -$18.92M | -$69.05M | -$36.92M | -$23.16M | -$22.18M | -$19.48M | -$16.70M | -$12.84M | -$18.84M |
| EPS (Diluted) | $-4.80 | $-0.89 | $-1.91 | $-1.08 | $-0.96 | $-1.35 | $-2.55 | $-3.59 | $-2.18 | $-24.67 |
| Total Assets | $76.88M | $86.44M | $98.36M | $95.83M | $69.77M | $39.52M | $25.45M | $14.54M | $11.14M | $18.15M |
| Total Liabilities | $295.48M | $134.46M | $130.43M | $59.75M | $44.37M | $20.66M | $10.86M | $6.85M | $3.41M | $8.43M |
| Shareholders' Equity | -$218.60M | -$48.02M | -$32.06M | $36.08M | $25.40M | $18.86M | $14.59M | $7.69M | $24.34M | $9.72M |
| Cash & Equivalents | $8.69M | $9.29M | $13.52M | $14.85M | $10.29M | $9.65M | $6.03M | $9.66M | $5.13M | $5.71M |
| Operating Cash Flow | -$25.76M | -$37.55M | -$47.42M | -$32.48M | -$23.57M | -$18.27M | -$15.58M | -$10.63M | -$9.19M | -$10.61M |
| Capital Expenditures | $542.0K | $1.88M | $8.14M | $2.21M | $1.30M | $824.0K | $224.0K | $875.0K | $58.0K | $279.0K |
| Shares Outstanding | 36.43M | 36.18M | 36.12M | 36.14M | 27.11M | 18.69M | 9.92M | 5.07M | 9.50M | 1.65M |